22mon MSN
Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...
Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.
As flu season trudges on and allergy season approaches, an untimely new recall prompts you to check your frequented medicine cabinet. Ascent Consumer Products Inc. is voluntarily recalling one lot of ...
In the United States, ONS-5010 / LYTENAVAâ„¢ (bevacizumab-vikg) is investigational.
Results of the Planned Interim Analysis and Update on Topline Read-out for the Essential3 Program: The Independent Data ...
Multiple moving parts have caused a shortage of eggs, starting with avian influenza and demand, David Murray writes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results